FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreThe No Surprises Act IDR process continues during the shutdown; timelines apply, portal is active, but CMS responses may be delayed.
The No Surprises Act Independent Dispute Resolution (IDR) process is not affected by the government shutdown. IDR entities are government contractors and as such, continue to process disputes; all standard dispute timelines continue to apply. The Federal IDR portal is also operational, allowing disputing parties to continue to submit claims. CMS responses to IDR complaints and inquiries may be delayed.
For more information, contact Katie Keysor, ACR® Senior Director of Economics and Health Policy.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more